secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGENUS INC (AGEN)
CIK:        0001098972
Form:       8-K
Filed at:   2024-12-05T23:59:59+00:00
Accession:  0000950170-24-133532
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 2.05, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Agenus strategic realignment: 60% annual cost cut, $100M cash burn target, workforce reduction
--------------------------------------------------------------------------------

- Agenus will reduce annual expenditures by 60% and target a cash burn of $100 million for fiscal year 2025.
- Workforce reduction with severance costs estimated at approximately $1.1 million; charges expected in Q1 2025.
- Company will focus resources on lead program botensilimab/balstilimab (BOT/BAL) for MSS CRC and other cancers.
- Agenus secured a $22M mortgage on real estate assets to support operational flexibility during restructuring.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1098972/000095017024133532/0000950170-24-133532-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1098972/000095017024133532/agen-20241205.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-133532

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer